Switch to
More onapp

How to use scorecard? Learn more

Morepen Laboratories Ltd

MOREPENLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,701 cr, stock is ranked 810
High RiskStock is 3.83x as volatile as Nifty
87.131.22 (-1.38%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,701 cr, stock is ranked 810
High RiskStock is 3.83x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
35.82
PB RatioPB Ratio
5.55
Dividend YieldDiv. Yield
Sector PESector PE
51.53
Sector PBSector PB
6.56
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Morepen Laboratories Limited is a pharmaceutical company. The Company operates through four segments; they are Active Pharmaceutical Ingredients (API), Domestic Formulations, Diagnostics and Over the Counter (OTC).

Financial TrendFinancial statements 

20212022202320241.201.561.421.700.100.100.040.10
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 2.57%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Press Release 
Announced OnDec 10, 2024

Morepen Laboratories Limited has informed the Exchange regarding a press release dated December 10, 2024, titled LightLife by Dr. Morepen: Scientific solution to long-lasting Weight Management | Download

Morepen Laboratories Limited has informed the Exchange regarding a press release dated December 10, 2024, titled LightLife by Dr. Morepen: Scientific solution to long-lasting Weight Management | Download

Agreements,Contracts,Arrangements,MOU-XBRL 
Announced OnDec 4, 2024

MOREPEN LABORATORIES LIMITED has informed the Exchange regarding DISTRIBUTION AGREEMENT | Download

MOREPEN LABORATORIES LIMITED has informed the Exchange regarding DISTRIBUTION AGREEMENT | Download

Others 
Announced OnDec 4, 2024

Morepen Laboratories Limited has informed the Exchange about disclosures under Regulation 30A of SEBI LODR Regulations. | Download

Morepen Laboratories Limited has informed the Exchange about disclosures under Regulation 30A of SEBI LODR Regulations. | Download

See all events